Evidence map›Paper›PMID 25646419›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

TCF1 and LEF1 act as T-cell intrinsic HTLV-1 antagonists by targeting Tax.

Guangyong Ma, Jun-ichirou Yasunaga, Hirofumi Akari, Masao Matsuoka

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Identification of AK4 and RHOC as potential oncogenes addicted by adult T cell leukemia.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Review
  3. Review
  4. TargetingFrontiers in immunology · 2021
    Article
  5. When Viruses Cross Developmental Pathways.Frontiers in cell and developmental biology · 2021
    Review
  6. Molecular biology of human T cell leukemia virus.Seminars in diagnostic pathology · 2020
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Human T-cell leukaemia virus type 1: parasitism and pathogenesis.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2017
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Guangyong MaLaboratory of Virus Control, Institute for Virus Research, Kyoto University, Kyoto 606-8507, Japan; and.
Jun-ichirou YasunagaLaboratory of Virus Control, Institute for Virus Research, Kyoto University, Kyoto 606-8507, Japan; and mmatsuok@virus.kyoto-u.ac.jp jyasunag@virus.kyoto-u.ac.jp.
Hirofumi AkariCenter for Human Evolution Modeling Research, Primate Research Institute, Kyoto University, Inuyama, Aichi 484-8506, Japan.
Masao MatsuokaLaboratory of Virus Control, Institute for Virus Research, Kyoto University, Kyoto 606-8507, Japan; and mmatsuok@virus.kyoto-u.ac.jp jyasunag@virus.kyoto-u.ac.jp.
Kyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) is a delta-type retrovirus that induces malignant and inflammatory diseases during its long persistence in vivo. HTLV-1 can infect various kinds of cells; however, HTLV-1 provirus is predominantly found in peripheral CD4 T cells in vivo. Here we find that TCF1 and LEF1, two Wnt transcription factors that are specifically expressed in T cells, inhibit viral replication through antagonizing Tax functions. TCF1 and LEF1 can each interact with Tax and inhibit Tax-dependent viral expression and activation of NF-κB and AP-1. As a result, HTLV-1 replication is suppressed in the presence of either TCF1 or LEF1. On the other hand, T-cell activation suppresses the expression of both TCF1 and LEF1, and this suppression enables Tax to function as an activator. We analyzed the thymus of a simian T-cell leukemia virus type 1 (STLV-1) infected Japanese macaque, and found a negative correlation between proviral load and TCF1/LEF1 expression in various T-cell subsets, supporting the idea that TCF1 and LEF1 negatively regulate HTLV-1 replication and the proliferation of infected cells. Thus, this study identified TCF1 and LEF1 as Tax antagonistic factors in vivo, a fact which may critically influence the peripheral T-cell tropism of this virus.

Indexed as

AnimalsCell LineDown-RegulationGene Products, taxHumansHuman T-lymphotropic virus 1Lymphoid Enhancer-Binding Factor 1MacacaSimian T-lymphotropic virus 1T Cell Transcription Factor 1Transcriptional ActivationViral LoadGene Products, taxLEF1 protein, humanLymphoid Enhancer-Binding Factor 1tax protein, Human T-lymphotrophic virus 1T Cell Transcription Factor 1TCF7 protein, humanHTLV-1LEF1TaxTCF1

Identifiers

PMID25646419
PMCPMC4343127
OpenAlexW1992115934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.